Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1V-Fend----[1] 299 💬
2V08CA02----[1] 13 💬
3V08CA09----[1] 13 💬
4V1512----[1] 6 💬
5V1512 and Entacapone[1] Entacapone[1] Entacapone 💬[1] COMT 💬[4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
6V565----[2] 96, 97 💬
7V81444----[1] 6 💬
8VA----[2] 90, 302 💬
9Vaccin grippal pandémique H1N1----[1] 299 💬
10Vaccination----[1] 49 💬
11Vaccination against TBE----[1] 46 💬
12Vaccination with vaccine against hepatitis A and B----[1] 299 💬
13Vaccine----[1] 49 💬
14Vaccine Vivotif + Vaccine Dukoral[6] Recombinant Cholera Toxin B Subunit,
Typhoid Vaccine Live,
Vibrio cholerae Inaba 48 classical biotype, heat inactivated,
Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, heat inactivated		---[1] 97 💬
15Vaccine Vivotif + Vaccine Dukoral + oats[7] Oat,
Recombinant Cholera Toxin B Subunit,
Typhoid Vaccine Live,
Vibrio cholerae Inaba 48 classical biotype, heat inactivated,
Vibrio cholerae Inaba 6973 El Tor biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, formalin inactivated,
Vibrio cholerae Ogawa 50 classical biotype, heat inactivated		---[1] 97 💬
16VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B----[3] 61, 62, 66 💬
17VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO----[2] 61, 62 💬
18VACCINO PNEUMOCOCCICO----[2] 62, 66 💬
19VACCINO PNEUMOCOCCICO SACCARIDICO----[1] 14 💬
20VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135)----[3] 61, 62, 66 💬
21VAD044----[1] 227 💬
22Vaginal estriol[1] Estriol[2] Estriol ,
Estriol tripropionate 💬		[2] ESR1,
ESR2 💬		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
23VAL-1221----[1] 256 💬
24Valacyclovir[1] Valaciclovir[2] Valaciclovir ,
Valaciclovir hydrochloride hydrate 💬		--[1] 65 💬
25Valbenazine[1] Valbenazine[1] Valbenazine 💬[1] SLC18A2 💬[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 8 💬
26Valdecoxib[1] Valdecoxib[1] Valdecoxib 💬[1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
27Valerian[1] Valerian---[1] 6 💬
28Valganciclovir[1] Valganciclovir[1] Valganciclovir 💬--[4] 85, 97, 299, 331 💬
29Valganciclovir (VGC)[1] Valganciclovir[1] Valganciclovir 💬--[1] 331 💬
30Valganciclovir [Valcyte][1] Valganciclovir[1] Valganciclovir 💬--[1] 299 💬
31Valiloxybate[1] Valiloxybate[1] Valiloxybate 💬[2] GABBR1,
GABBR2 💬		[7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
32Valproate[1] Valproic acid[1] Valproic acid 💬[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		[17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[6] 2, 3, 90, 102, 233, 256 💬
33VALPROATE SODIUM[1] Valproic acid[1] Valproic acid 💬[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		[17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
34Valproate, Levocarnitine[2] Levocarnitine,
Valproic acid		[2] Valproic acid ,
Levocarnitine 💬		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		[17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
35Valproic Acid[1] Valproic acid[1] Valproic acid 💬[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		[17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[7] 3, 5, 26, 65, 90, 222, 256 💬
36Valproic Acid (VPA)[1] Valproic acid[1] Valproic acid 💬[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		[17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
37Valproic Acid and Levocarnitine[2] Levocarnitine,
Valproic acid		[2] Valproic acid ,
Levocarnitine 💬		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬		[17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
38Valproid acid plus corticosteroids----[1] 26 💬
39Valsartan[1] Valsartan[1] Valsartan 💬[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[7] 57, 58, 66, 75, 218, 222, 224 💬
40Vamarolone----[1] 113 💬
41Vaminolac----[1] 97 💬
42Vaminolac, komb.----[1] 97 💬
43Vamorolone[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 97, 113 💬
44Vamorolone 0.25 mg/day/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
45Vamorolone 0.25 mg/kg/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
46Vamorolone 0.75 mg/day/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
47Vamorolone 0.75 mg/kg/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
48Vamorolone 2.0 mg/day/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
49Vamorolone 2.0 mg/kg/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
50Vamorolone 4% suspension for oral dosing[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
51Vamorolone 6.0 mg/day/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
52Vamorolone 6.0 mg/kg/day[1] Vamorolone[1] Vamorolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
53Vancomycin[1] Vancomycin[1] Vancomycin 💬--[8] 13, 46, 70, 94, 96, 97, 296, 299 💬
54Vancomycin hydrochloride inhalation powder[1] Vancomycin[1] Vancomycin 💬--[1] 299 💬
55Vancomycin inhalation powder[1] Vancomycin[1] Vancomycin 💬--[1] 299 💬
56Vancomycin Oral Capsule[1] Vancomycin[1] Vancomycin 💬--[1] 97 💬
57Vancomycin Pre-Treat[1] Vancomycin[1] Vancomycin 💬--[1] 97 💬
58Vancomycin Pre-Treatment[1] Vancomycin[1] Vancomycin 💬--[1] 97 💬
59Vantobra (tobramycin)[1] Tobramycin[1] Tobramycin 💬--[1] 299 💬
60Vardenafil[1] Vardenafil[1] Vardenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[3] 13, 86, 299 💬
61Vardenafil (hidrocloride)[1] Vardenafil[1] Vardenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 13 💬
62Vardenafilo[1] Vardenafil[1] Vardenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 13 💬
63VARDENAFILO HIDROCLORURO[1] Vardenafil[1] Vardenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 13 💬
64VARENICLINE[1] Varenicline[1] Varenicline 💬[2] CHRNA4,
CHRNB2 💬		[4] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[3] 6, 18, 53 💬
65Varenicline Nasal Spray[1] Varenicline[1] Varenicline 💬[2] CHRNA4,
CHRNB2 💬		[4] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 53 💬
66VARENICLINE TARTRATE[1] Varenicline[1] Varenicline 💬[2] CHRNA4,
CHRNB2 💬		[4] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 6 💬
67VARI----[2] 62, 274 💬
68Variation of behaviors of Parkinson's disease----[1] 6 💬
69Varicella Zoster Vaccine----[1] 46 💬
70Various----[1] 95 💬
71Vaseline----[1] 51 💬
72Vasoactive intestinal peptide----[1] 85 💬
73Vasomera (PB1046) Injection----[1] 86 💬
74Vasopressin[1] Vasopressin[1] Vasopressin 💬[3] AVPR1A,
AVPR1B,
AVPR2 💬		[5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 210 💬
75Vasopressin, Arginine[2] Arginine,
Vasopressin		[2] Vasopressin ,
Arginine 💬		[3] AVPR1A,
AVPR1B,
AVPR2 💬		[5] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 210 💬
76Vastarel----[2] 2, 58 💬
77Vastarel 20mg film coated tablets----[1] 58 💬
78Vatelizumab[1] Vatelizumab---[2] 13, 97 💬
79VATIQUINONE[1] Vatiquinone[1] Vatiquinone 💬--[2] 18, 21 💬
80Vaxzevria[1] AstraZeneca COVID-19 Vaccine---[1] 299 💬
81Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S[1] AstraZeneca COVID-19 Vaccine---[1] 299 💬
82VAY736----[9] 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
83VAY736 antibody----[1] 53 💬
84VAY736 higher dose----[1] 53 💬
85VAY736 lower dose----[1] 53 💬
86VB-201[1] VB-201---[1] 97 💬
87VB-201 160mg[1] VB-201---[1] 97 💬
88VB119----[1] 222 💬
89VB13S1----[1] 13 💬
90VB5S2----[1] 13 💬
91VB6S5----[1] 13 💬
92VBP15----[1] 113 💬
93VE202----[1] 97 💬
94Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana----[1] 19 💬
95Vectra DA MBDA Test----[1] 46 💬
96VEDOLIZUMAB[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[3] 94, 96, 97 💬
97Vedolizumab (Genetical Recombination)[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
98Vedolizumab 108 mg SC[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
99Vedolizumab 300 mg[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
100Vedolizumab 300 MG Injection [Entyvio][1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
101Vedolizumab 300 mg IV[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
102Vedolizumab Injection[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
103Vedolizumab Intravenous (IV), Vedolizumab Subcutaneous (SC), Placebo IV[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
104Vedolizumab intravenous injection[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
105Vedolizumab IV[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[3] 94, 96, 97 💬
106Vedolizumab IV (Entyvio¿)[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
107Vedolizumab IV (Entyvio™)[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
108Vedolizumab IV 300 mg[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
109Vedolizumab IV, Placebo IV, Placebo SC[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
110Vedolizumab IV, Placebo SC[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
111Vedolizumab SC[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
112Vedolizumab SC 108 mg[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
113Vedolizumab subcutaneous injection[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
114Vedolizumab, Entyvio[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
115Vedolizumab, Ustekinumab, or Tofacitinib[3] Tofacitinib,
Ustekinumab,
Vedolizumab		[3] Vedolizumab ,
Ustekinumab ,
Tofacitinib 💬		[9] IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
JAK1,
JAK2,
JAK3,
TYK2 💬		[65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬[1] 97 💬
116Vedolizumab-800CW[1] Vedolizumab[1] Vedolizumab 💬[2] ITGA4,
ITGB7 💬		[15] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
117VEDROP[1] Tocofersolan[1] Tocophersolan 💬--[1] 299 💬
118VEDULIZUMAB----[1] 97 💬
119Vehice Control----[1] 96 💬
120Vehicle----[4] 6, 36, 160, 192 💬
121Vehicle (SD-101 0%)----[1] 36 💬
122Vehicle Control----[1] 53 💬
123Vehicle Cream----[1] 36 💬
124Vehicle eye drops----[1] 90 💬
125Vehicle Gel----[2] 13, 34 💬
126Vehicle of ADX-102 Topical Dermal Cream----[1] 160 💬
127Vehicle ophthalmic solution----[1] 53 💬
128VELAGLUCERASE ALFA[1] Velaglucerase alfa[1] Velaglucerase alfa 💬[1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
129Velaglucerasi alfa----[1] 19 💬
130Velamox----[1] 11 💬
131Velcade[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[3] 11, 28, 61 💬
132VELCADE*1FL 3,5MG[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
133VELCADE*EV 1FL 3,5MG 1MG/ML[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 61 💬
134Velcade®[2] Bortezomib,
Bortezomib D-mannitol		[1] Bortezomib 💬[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 11 💬
135Veldona----[1] 56 💬
136Veldona,----[1] 56 💬
137Veledimex[1] Veledimex[1] Veledimex 💬--[1] 51 💬
138Veletri[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
139VELMANASE ALFA[1] Velmanase alfa[1] Velmanase alfa 💬[1] MAN2B1 💬[2] Lysosome, Other glycan degradation 💬[1] 19 💬
140Velmanase Alfa (e.g. Lamazym)[1] Velmanase alfa[1] Velmanase alfa 💬[1] MAN2B1 💬[2] Lysosome, Other glycan degradation 💬[1] 19 💬
141Veltuzumab[1] Veltuzumab[1] Veltuzumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46 💬
142Veltuzumab solution 75mg/ml[1] Veltuzumab[1] Veltuzumab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46 💬
143Velusetrag[1] Velusetrag[1] Velusetrag 💬[1] HTR4 💬[4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[1] 99 💬
144Venetoclax[1] Venetoclax[1] Venetoclax 💬[1] BCL2 💬[43] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬
145Venetoclax MTD with Dexamethasone[2] Dexamethasone,
Venetoclax		[2] Dexamethasone ,
Venetoclax 💬		[2] BCL2,
NR3C1 💬		[44] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬
146Venetoclax Oral Tablet, 200 mg[1] Venetoclax[1] Venetoclax 💬[1] BCL2 💬[43] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬
147Venetoclax Oral Tablet, 400 mg[1] Venetoclax[1] Venetoclax 💬[1] BCL2 💬[43] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬
148Venglustat[1] Venglustat[1] Venglustat 💬[1] UGCG 💬[2] Metabolic pathways, Sphingolipid metabolism 💬[3] 6, 19, 67 💬
149Venglustat (GZ402671)[1] Venglustat[1] Venglustat 💬[1] UGCG 💬[2] Metabolic pathways, Sphingolipid metabolism 💬[1] 19 💬
150Venglustat GZ/SAR402671[1] Venglustat[1] Venglustat 💬[1] UGCG 💬[2] Metabolic pathways, Sphingolipid metabolism 💬[2] 6, 67 💬
151Venglustat GZ402671[1] Venglustat[1] Venglustat 💬[1] UGCG 💬[2] Metabolic pathways, Sphingolipid metabolism 💬[2] 19, 67 💬
152Venglustat malate[1] Venglustat[1] Venglustat 💬[1] UGCG 💬[2] Metabolic pathways, Sphingolipid metabolism 💬[3] 6, 19, 67 💬
153Venglustat malato[1] Venglustat[1] Venglustat 💬[1] UGCG 💬[2] Metabolic pathways, Sphingolipid metabolism 💬[2] 19, 67 💬
154Venlafaxin Hexal----[1] 13 💬
155Venlafaxine[1] Venlafaxine[1] Venlafaxine 💬[2] SLC6A2,
SLC6A4 💬		[2] Serotonergic synapse, Synaptic vesicle cycle 💬[3] 6, 13, 46 💬
156VENLAFAXINE HYDROCHLORIDE[1] Venlafaxine[1] Venlafaxine 💬[2] SLC6A2,
SLC6A4 💬		[2] Serotonergic synapse, Synaptic vesicle cycle 💬[2] 13, 46 💬
157Venous blood sample----[1] 46 💬
158Ventavis[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
159Ventavis (Iloprost, BAYQ6256)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
160Ventavis 10[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
161Ventavis(Iloprost)[1] Iloprost[1] Iloprost 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
162Ventolin[1] Salbutamol[1] Albuterol 💬[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
163Ventoline----[1] 111 💬
164Ventoline oral solution 0,4mg/ml----[1] 111 💬
165Ventoline tablet 2mg----[1] 111 💬
166Ventolin® Evohaler[1] Salbutamol[1] Albuterol 💬[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
167Ventolin¿ Evohaler¿[1] Salbutamol[1] Albuterol 💬[1] ADRB2 💬[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
168Verapamil[1] Verapamil[1] Verapamil 💬[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 58, 96, 140, 167 💬
169VERAPAMIL HYDROCHLORIDE[1] Verapamil[1] Verapamil 💬[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58 💬
170Verapamil SR[1] Verapamil[1] Verapamil 💬[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 167 💬
171Verde de Indocianina (Indocyanine Green)[1] Indocyanine green[1] Indocyanine green 💬--[1] 235 💬
172Verdiperstat[1] Verdiperstat[1] Verdiperstat 💬[1] MPO 💬[5] Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬[3] 2, 17, 127 💬
173Veregen[1] Sinecatechins[1] Sinecatechins 💬--[1] 160 💬
174VEREGEN(R)[1] Sinecatechins[1] Sinecatechins 💬--[1] 160 💬
175Verorab® (PVRV----[1] 65 💬
176Versus hydroxychloroquine[1] Hydroxychloroquine[1] Hydroxychloroquine 💬--[1] 49 💬
177Verum arm receiving Gilenya®----[1] 13 💬
178Verum arm receiving Vitamin D oil[1] Vitamin D---[1] 13 💬
179VESANOID[1] Tretinoin[1] Tretinoin 💬[3] PML,
RARA,
RARB 💬		[12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[1] 75 💬
180VESIcare 10Mg Tablet----[1] 13 💬
181Vessel----[2] 51, 271 💬
182Vestronidase alfa[1] Vestronidase alfa[1] Vestronidase alfa 💬[1] GUSB 💬[8] Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬[1] 19 💬
183Vett Lentiviral con gene ABCA4----[1] 301 💬
184VEYONDI 650IU powder and solvent for solution for injection----[1] 288 💬
185Veyvondi[1] Vonicog alfa[1] Vonicog alfa 💬--[1] 288 💬
186VEYVONDI 1300 IU powder and solvent for solution for injection[1] Vonicog alfa[1] Vonicog alfa 💬--[1] 288 💬
187VEYVONDI 1300I IU powder and solvent for solution for injection[1] Vonicog alfa[1] Vonicog alfa 💬--[1] 288 💬
188VEYVONDI 1300IU powder and solvent for solution for injection[1] Vonicog alfa[1] Vonicog alfa 💬--[1] 288 💬
189VEYVONDI 650IU powder and solvent for solution for injection[1] Vonicog alfa[1] Vonicog alfa 💬--[1] 288 💬
190Vfend[1] Voriconazole[1] Voriconazole 💬--[1] 299 💬
191VFEND 40 mg/ml powder for oral suspension[1] Voriconazole[1] Voriconazole 💬--[1] 299 💬
192VGB-ST----[1] 145 💬
193VGB-ST soluble tablets----[1] 145 💬
194VIAGRA[1] Sildenafil[1] Sildenafil 💬[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[3] 86, 96, 225 💬
195VIALEBEX----[1] 96 💬
196Vialebex 200mg----[1] 96 💬
197Viaskin Milk 500 mcg[1] Cow milk---[1] 98 💬
198VIB0551----[1] 13 💬
199VIB4920----[2] 46, 53 💬
200VIB4920 with TNFi----[1] 46 💬
201VIB4920 without TNFi----[1] 46 💬
202VIB7734----[4] 49, 50, 51, 53 💬
203VIB7734, MEDI7734----[1] 49 💬
204Vibrox----[1] 167 💬
205Vibrox 100mg Capsules----[1] 167 💬
206Vidofludimus[1] Vidofludimus---[5] 13, 46, 94, 96, 97 💬
207VIDOFLUDIMUS CALCIUM[2] Calcium,
Vidofludimus		---[4] 13, 94, 96, 97 💬
208Vidofludimus calcium dihydrate[2] Calcium,
Vidofludimus		---[1] 97 💬
209VIGABATRIN[1] Vigabatrin[1] Vigabatrin 💬[1] ABAT 💬[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[2] 145, 158 💬
210Vigabatrin (Sabril)[1] Vigabatrin[1] Vigabatrin 💬[1] ABAT 💬[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 158 💬
211Vigabatrin Tablets[1] Vigabatrin[1] Vigabatrin 💬[1] ABAT 💬[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
212Vigabatrin: Vigabatrin new ST formulation then Sabril®[1] Vigabatrin[1] Vigabatrin 💬[1] ABAT 💬[7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
213Vigantol----[4] 13, 65, 96, 97 💬
214Vigantol Oel----[3] 13, 96, 97 💬
215Vigantol Oel TM----[2] 96, 97 💬
216VIGANTOL OIL----[1] 13 💬
217VigantOL oil plus interferon beta-1a (Rebif)[2] Human interferon beta,
Interferon beta-1a		[1] Interferon beta-1a 💬[2] IFNAR1,
IFNAR2 💬		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
218Vigantol® Oil----[1] 13 💬
219Vigantol® Öl 20.000 I.E./ml----[1] 13 💬
220Vilobelimab[1] Vilobelimab[1] Vilobelimab 💬[1] C5 💬[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[2] 43, 44 💬
221VILTOLARSEN[1] Viltolarsen[1] Viltolarsen 💬[1] DMD 💬[4] Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬[1] 113 💬
222Vimizim® (elosulfase alfa)[1] Elosulfase alfa[1] Elosulfase alfa 💬[1] GALNS 💬[3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬[1] 19 💬
223VIMOVO 250/20----[1] 107 💬
224VIMOVO 375/20----[1] 107 💬
225VIMOVO 500/20----[1] 107 💬
226Vinblastine[1] Vinblastine[1] Vinblastine 💬[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[2] 34, 65 💬
227Vinblastine sulfate[2] Sulfate ion,
Vinblastine		[1] Vinblastine 💬[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[1] 34 💬
228VINBLASTINE SULPHATE[1] Vinblastine[1] Vinblastine 💬[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[1] 34 💬
229Vinblastine, vincristine, prednisone, daunorubicin[4] Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		[4] Prednisone ,
Daunorubicin ,
Vinblastine ,
Vincristine 💬		[12] NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬[1] 65 💬
230Vincristine[1] Vincristine[1] Vincristine 💬[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[4] 26, 34, 65, 331 💬
231Vincristine Sulfate[2] Sulfate ion,
Vincristine		[1] Vincristine 💬[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[1] 26 💬
232Vincristine Sulfate (Oncovin)[2] Sulfate ion,
Vincristine		[1] Vincristine 💬[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		[10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬[1] 34 💬
233ViNeuro----[1] 6 💬
234VIOKASE 16----[1] 298 💬
235Viokase 16 (pancrelipase) + Nexium[2] Esomeprazole,
Pancrelipase		[2] Pancrelipase ,
Esomeprazole 💬		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 298 💬
236Viokase® 16----[1] 298 💬
237VIP----[3] 49, 51, 86 💬
238Viral load driven treatment interruption----[1] 265 💬
239VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE----[1] 46 💬
240VIREAD 30 CPR 245 MG----[1] 46 💬
241VIS649----[1] 66 💬
242Viscous/swallowed budesonide[1] Budesonide[1] Budesonide 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
243Visilizumab[1] Visilizumab[1] Visilizumab 💬[3] CD3D,
CD3E,
CD3G 💬		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[2] 96, 97 💬
244Visilizumab (HuM291[1] Visilizumab[1] Visilizumab 💬[3] CD3D,
CD3E,
CD3G 💬		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 97 💬
245Visilizumab (Nuvion)[1] Visilizumab[1] Visilizumab 💬[3] CD3D,
CD3E,
CD3G 💬		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 97 💬
246Visilizumab (Nuvion®[1] Visilizumab[1] Visilizumab 💬[3] CD3D,
CD3E,
CD3G 💬		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 97 💬
247VISMODEGIB[1] Vismodegib[1] Vismodegib 💬[1] SMO 💬[5] Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬[1] 85 💬
248Vit C Vit E Zn Se----[1] 113 💬
249Vit D----[1] 227 💬
250Vitamin A[1] Vitamin A[1] Vitamin A 💬[2] RARA,
RARB 💬		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[3] 13, 53, 90 💬
251Vitamin AD sig: 1 tablet/tid----[1] 90 💬
252Vitamin B sig: 10mg/tid----[1] 90 💬
253Vitamin B1[1] Thiamine[1] Thiamine 💬--[1] 145 💬
254Vitamin B12[1] Cyanocobalamin[4] Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--[4] 6, 201, 229, 299 💬
255Vitamin B12 Supplementation[1] Cyanocobalamin[4] Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--[1] 6 💬
256Vitamin B12, B9, B6, C supplementation[1] Cyanocobalamin[4] Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--[1] 229 💬
257Vitamin B2[1] Riboflavin[1] Riboflavin 💬--[1] 97 💬
258Vitamin B3----[1] 107 💬
259Vitamin B6[1] Pyridoxine[1] Pyridoxine 💬--[2] 6, 206 💬
260Vitamin B7[1] Biotin[1] Biotin 💬--[1] 8 💬
261Vitamin C[1] Ascorbic acid[1] Ascorbic acid 💬--[6] 10, 192, 206, 210, 211, 212 💬
262Vitamin D[2] Cholecalciferol,
Vitamin D		[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[20] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299 💬
263Vitamin D 100ug[1] Vitamin D---[1] 298 💬
264Vitamin D 10ug[1] Vitamin D---[1] 298 💬
265Vitamin D 2[1] Vitamin D---[1] 46 💬
266Vitamin D 25(OH)D[1] Vitamin D---[1] 49 💬
267Vitamin D drops[1] Vitamin D---[2] 96, 97 💬
268Vitamin D in arm B[1] Vitamin D---[1] 46 💬
269Vitamin D Oil[1] Vitamin D---[1] 299 💬
270Vitamin D Powder[1] Vitamin D---[1] 299 💬
271Vitamin D2[1] Ergocalciferol[1] Ergocalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[3] 49, 84, 299 💬
272Vitamin D2 ( calciferol )[2] Ergocalciferol,
Vitamin D		[1] Ergocalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 49 💬
273Vitamin D3[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[12] 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
274Vitamin D3 - high dose[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 6 💬
275Vitamin D3 3000 UI daily[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 96 💬
276Vitamin D3 400 IU[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 49 💬
277Vitamin D3 4000 UI daily[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 96 💬
278Vitamin D3 6000 IU[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 49 💬
279Vitamin D3 800 UI/day then 800 UI/day[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 96 💬
280Vitamin D3: 3000 or 4000 UI/day then 2,000 UI/day[1] Cholecalciferol[1] Cholecalciferol 💬[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 96 💬
281Vitamin E[1] Vitamin E[1] Vitamin E 💬--[11] 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 💬
282VITAMIN E - TGPS[1] Vitamin E[1] Vitamin E 💬--[1] 299 💬
283Vitamin E 800IU[1] Vitamin E[1] Vitamin E 💬--[2] 96, 97 💬
284Vitamin E supplement[1] Vitamin E[1] Vitamin E 💬--[1] 317 💬
285Vitamin E/Selenium[2] Selenium,
Vitamin E		[1] Vitamin E 💬--[1] 13 💬
286Vitamin K[1] Phylloquinone---[2] 46, 299 💬
287Vitamin K supplementation, dose #1[1] Phylloquinone---[1] 299 💬
288Vitamin K supplementation, dose #2[1] Phylloquinone---[1] 299 💬
289Vitamin K1[1] Phylloquinone---[2] 46, 96 💬
290Vitamin K1 Tablets[1] Phylloquinone---[1] 46 💬
291Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1[1] Choline[1] Choline 💬--[1] 299 💬
292Vitamina D e calcio[1] Calcium---[1] 274 💬
293VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA----[1] 13 💬
294Vitamins: B6, B12, and folate[1] Folic acid[1] Folic acid 💬--[1] 49 💬
295VIUSID/ALZER----[1] 6 💬
296Vivaglobin----[2] 14, 65 💬
297ViviGen Cellular Bone Matrix----[1] 70 💬
298Vivomixx probiotics----[1] 51 💬
299Vivotif[1] Typhoid Vaccine Live---[1] 97 💬
300Vizamyl[1] Flutemetamol (18F)---[3] 5, 7, 127 💬
301Vizamyl (flutemetamol(F-18))[2] Flutemetamol,
Flutemetamol (18F)		---[3] 5, 7, 127 💬
302VK0214----[1] 20 💬
303VM106----[1] 65 💬
304VM202----[1] 2 💬
305VNX001----[1] 226 💬
306VO4CX----[1] 296 💬
307Vobarilizumab[1] Vobarilizumab[1] Vobarilizumab 💬--[1] 49 💬
308Voclosporin[1] Voclosporin[1] Voclosporin 💬[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[2] 49, 222 💬
309Volanesorsen[1] Volanesorsen[1] Volanesorsen 💬[1] APOC3 💬[2] Cholesterol metabolism, PPAR signaling pathway 💬[1] 265 💬
310VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide[1] Volanesorsen[1] Volanesorsen 💬[1] APOC3 💬[2] Cholesterol metabolism, PPAR signaling pathway 💬[1] 265 💬
311Volibris[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[4] 51, 85, 86, 88 💬
312VOLIBRIS 10 mg comprimidos recubiertos con película[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
313VOLIBRIS 5 mg comprimidos recubiertos con película[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
314VOLIBRIS® (ambrisentan)[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
315VOLIBRIS™ tablets[1] Ambrisentan[1] Ambrisentan 💬[1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
316Volixibat[1] Volixibat[1] Volixibat 💬--[2] 93, 94 💬
317Volixibat (formely SHP626, LUM002 or SAR548304B)[1] Volixibat[1] Volixibat 💬--[1] 94 💬
318Volixibat potassium[2] Potassium,
Volixibat		[2] Potassium ,
Volixibat 💬		--[2] 93, 94 💬
319VOLMAX*30CPR 4MG R.P.----[1] 3 💬
320Voltaren resinat----[1] 271 💬
321Voltarol----[1] 46 💬
322Voltarol SR----[1] 46 💬
323Voltarol SR (generics also available in the EU)----[1] 46 💬
324Voltrarol SR----[1] 46 💬
325Von willebrand factor[1] Von Willebrand factor human---[2] 64, 288 💬
326Von Willebrand factor (Recombinant)[1] Von Willebrand factor human---[1] 288 💬
327Von Willebrand factor and coagulation factor VIII in combination[2] Beroctocog alfa,
Von Willebrand factor human		---[1] 288 💬
328Von Willebrand Factor Antigen[1] Von Willebrand factor human---[1] 288 💬
329Von Willebrand Factor Ristocetin Cofactor[1] Von Willebrand factor human---[1] 288 💬
330Von Willebrand Faktor----[1] 288 💬
331Voncento[2] Antihemophilic factor human,
Von Willebrand factor human		---[1] 288 💬
332Voncento, Biostate®[2] Antihemophilic factor human,
Von Willebrand factor human		---[1] 288 💬
333Voncento®[1] Von Willebrand factor human---[1] 288 💬
334VONICOG ALFA[1] Vonicog alfa[1] Vonicog alfa 💬--[1] 288 💬
335Vonoprazan[1] Vonoprazan[1] Vonoprazan 💬[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[2] 63, 98 💬
336Voriconazole[1] Voriconazole[1] Voriconazole 💬--[2] 60, 299 💬
337Vorinostat[1] Vorinostat[1] Vorinostat 💬[11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬		[17] Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[2] 75, 96 💬
338Vorsoritide----[1] 276 💬
339Vortioxetine[1] Vortioxetine[1] Vortioxetine 💬[7] HTR1A,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E,
SLC6A4 💬		[5] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
340Vosoritide[1] Vosoritide[1] Vosoritide 💬[1] NPR2 💬[5] Metabolic pathways, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 276 💬
341Votubia[1] Everolimus[1] Everolimus 💬[1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[2] 34, 158 💬
342VPA----[1] 3 💬
343VPD-737----[1] 36 💬
344VPRIV[1] Velaglucerase alfa[1] Velaglucerase alfa 💬[1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
345VPRIV - 400 U - POLVERE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO[1] Velaglucerase alfa[1] Velaglucerase alfa 💬[1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
346VPRIV 400 Units powder for solution of infusion[1] Velaglucerase alfa[1] Velaglucerase alfa 💬[1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
347VPRIV ®,[1] Velaglucerase alfa[1] Velaglucerase alfa 💬[1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
348VPRIV®[1] Velaglucerase alfa[1] Velaglucerase alfa 💬[1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
349VR040----[1] 6 💬
350VR040/Aspirair® inhaler----[1] 6 💬
351VR496----[1] 299 💬
352VRP700----[1] 85 💬
353VRS-317----[1] 78 💬
354VRT-813077----[1] 299 💬
355VRT-826809----[1] 299 💬
356VRT-893661----[1] 299 💬
357VRT-893661 VRT-0893661----[1] 299 💬
358VSL#3----[4] 96, 97, 107, 291 💬
359VSL#3®----[2] 96, 97 💬
360VSN16R----[1] 13 💬
361VSN16R 100mg----[1] 13 💬
362VT-001----[1] 66 💬
363VTS-270----[1] 19 💬
364VTX-801----[1] 171 💬
365VTX002----[1] 97 💬
366VTX002 is not biologic----[1] 97 💬
367VTX958----[1] 96 💬
368VWD factor VIII concentrate[1] Beroctocog alfa---[1] 288 💬
369VWF gene analysis----[1] 288 💬
370VWF replacement therapy with Wilate[1] Von Willebrand factor human---[1] 288 💬
371VWF SD-35-DH----[1] 288 💬
372VWF-containing products----[1] 288 💬
373VWF/FVIII products----[1] 288 💬
374VX-121----[1] 299 💬
375VX-121/TEZ/D-IVA----[1] 299 💬
376VX-121/tezacaftor/deutivacaftor[2] Deutivacaftor,
Tezacaftor		[2] Tezacaftor ,
Deutivacaftor 💬		[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
377VX-147----[1] 222 💬
378VX-152----[1] 299 💬
379VX-371----[1] 299 💬
380VX-371 in hypertonic saline----[1] 299 💬
381VX-371 in saline----[1] 299 💬
382VX-440----[1] 299 💬
383VX-445----[1] 299 💬
384VX-445 / TEZ / IVA----[1] 299 💬
385VX-445 / TEZ / IVA FDC----[1] 299 💬
386VX-445 /TEZ/IVA----[1] 299 💬
387VX-445/TEZ/IVA----[1] 299 💬
388VX-509----[1] 46 💬
389VX-522 mRNA therapy----[1] 299 💬
390VX-561----[1] 299 💬
391VX-561 (CTP-656)----[1] 299 💬
392VX-634----[1] 231 💬
393VX-659[1] VX-659---[1] 299 💬
394VX-659/ TEZ/IVA[1] VX-659---[1] 299 💬
395VX-659/TEZ/IVA[1] VX-659---[1] 299 💬
396VX-659/Tezacaftor/Ivacaftor[3] Ivacaftor,
Tezacaftor,
VX-659		[2] Ivacaftor ,
Tezacaftor 💬		[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
397VX-661----[1] 299 💬
398VX-661 / VX-770----[1] 299 💬
399VX-661 Plus Ivacaftor Combination[1] Ivacaftor[1] Ivacaftor 💬[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
400VX-661, VRT-893661----[1] 299 💬
401VX-661/Ivacaftor[1] Ivacaftor[1] Ivacaftor 💬[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
402VX-661/ivacaftor (VX-770) 100mg/150 mg[1] Ivacaftor[1] Ivacaftor 💬[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
403VX-661/ivacaftor 100 mg/ 150 mg[1] Ivacaftor[1] Ivacaftor 💬[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
404VX-661/ivacaftor 100mg/150 mg[1] Ivacaftor[1] Ivacaftor 💬[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
405VX-661/ivacaftor 100mg/150mg[1] Ivacaftor[1] Ivacaftor 💬[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
406VX-661/ivacaftor 50 mg/ 75 mg[1] Ivacaftor[1] Ivacaftor 💬[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
407VX-661/VX-770----[1] 299 💬
408VX-661/VX-770 (TEZ/IVA)----[1] 299 💬
409VX-668----[1] 231 💬
410VX-702[1] VX-702---[1] 46 💬
411VX-745----[1] 8 💬
412VX-77----[1] 299 💬
413VX-770----[1] 299 💬
414VX-770, VRT-8130077----[1] 299 💬
415VX-770, VRT-813077----[1] 299 💬
416VX-809----[1] 299 💬
417VX-809 & VX-770----[1] 299 💬
418VX-809 / VX-770----[1] 299 💬
419VX-809, VRT-826809----[1] 299 💬
420VX-809/VX-770----[1] 299 💬
421VX-814----[1] 231 💬
422VX-864----[1] 231 💬
423VX147----[1] 222 💬
424VX15/2503----[2] 8, 13 💬
425VX864----[1] 231 💬
426VY-AADC01----[1] 6 💬
427VY-AADC02----[1] 6 💬
428Vyndaqel[1] Tafamidis[1] Tafamidis 💬[1] TTR 💬[1] Thyroid hormone synthesis 💬[1] 28 💬
429Vyndaqel 20mg soft capsule[1] Tafamidis[1] Tafamidis 💬[1] TTR 💬[1] Thyroid hormone synthesis 💬[1] 28 💬
430VYNT-0126----[1] 156 💬
431Vyondys 53[1] Golodirsen[1] Golodirsen 💬[1] DMD 💬[4] Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬[1] 113 💬